| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +5.3M | 98.8% | $5.00 | +$26.5M |
| Sells | 2 | -64K | 1.2% | $5.88 | -$376K |
| Net | 0 | +5.24M | 97.6% | +$26.1M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| GSK plc | 10%+ Owner | $69.9M | +$16.5M | +30.9% | Dec 7, 2023 |
| Ken Takanashi | Director, 10%+ Owner | $14.2M | Aug 12, 2024 | ||
| Paul Bolno | President and CEO, Director | $2.08M | -$280K | -11.9% | Aug 21, 2024 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | $459K | Jul 22, 2024 | ||
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | $399K | Feb 5, 2024 | ||
| Kyle Moran | Chief Financial Officer | $209K | -$96.4K | -31.5% | Apr 3, 2024 |
| Gregory L. Verdine | Director | $114K | Aug 12, 2024 | ||
| Heidi Wagner | Director | $79.9K | Aug 12, 2024 | ||
| Mark Corrigan | Director | $79.9K | Aug 12, 2024 | ||
| Ra Capital Management, L.P. | Director, 10%+ Owner | $40K | +$10M | Aug 12, 2024 | |
| Christian Henry | Director | $40K | Aug 12, 2024 | ||
| Adrian Rawcliffe | Director | $40K | Aug 12, 2024 | ||
| Aik Na Tan | Director | $40K | Aug 12, 2024 | ||
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | Jul 25, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|